
Biotechnology
Innovations in cancer immunotherapy: Bi-specific T cell engagers
Bi-specific T cell engagers are poised to become key immunotherapy treatments due to simpler production and new safety advances.
The CAS Inventory Expert Service (IES) helps you obtain CA Index Names and CAS Registry Numbers® in order to complete your EPA TSCA PMN application under the Revisions of Premanufacture Notification Regulations: Final Rule.
CAS service professionals are available to answer questions and help you with requests.
800.631.1884 (North America)
614.447.3870 (Outside North America)
answers@cas.org


